Abstract IA004: Risk of therapy-related subsequent cancers in individuals with germline TP53 variants
Villani, Anita, Khincha, Payal, Hatton, Jessica, Schonfeld, Sara, Goudie, Catherine, Oba, Leatrisse, Pithadia, Kishan, Sänger, Birte, Kratz, Christian, Le, Anh N., Orr, Caitlin, Maxwell, Kara N., Naumer, Anne, Vagher, Jennie, Kohlmann, Wendy, Schiffman, Joshua, Santana dos Santos, Elizabeth, Michaeli, Orli, Carson, Jacob J., Tsang, Derek S., Kim, Raymond, Maciaszek, Jamie L., Nichols, Kim E., Goodman, Victoria E., MacFarland, Suzanne P., Reichman, Lara, Achatz, Maria Isabel, Savage, Sharon, Malkin, David, Morton, Lindsay M.
Published in Cancer research (Chicago, Ill.) (05.09.2024)
Published in Cancer research (Chicago, Ill.) (05.09.2024)
Get full text
Journal Article